Pre-book period is over. Planning time is over. Seqirus has ample inventory to support orders throughout the season to supplement pre-book orders. Through our partnership with Seqirus, you can access a 5-9% discount off standard GPO pricing.
AFLURIA® TRIVALENT (Individuals 6 Months of Age and Older)
0.5mL single-dose syringes (10/pack) for 36+ months.
$145.21 per package or $14.52 per dose.
FLUAD® TIV (Individuals 65 Years and Older)
0.5mL single-dose syringes (10/pack).
$596.85 per package or $59.69 per dose.
FLUCELVAX® TIV (Individuals 6 Months of Age and Older)
0.5mL single-dose syringes (10/pack).
$227.68 per package or $22.77 per dose.
Contact your McKesson representative now to order your flu vaccines for the 2025-2026 virus season.
Important Details
- Available to purchase through McKesson distribution and direct from Seqirus.
- Members that placed a pre-book order before May 2nd will receive the additional 3% pre-book discount and will also access that price on any incremental orders placed throughout the season (as long as supply is available).
- Pricing above does not include the federal excise tax ($0.75 per dose).
- Pricing is net member pricing and no additional distributor markup should be applied.
- You must be activated on our Rx portfolio with a HIN or DEA to take advantage of enhanced pricing.
- The CDC and ACIP have issued a joint statement including the recommendation that all adults receive seasonal influenza vaccines only in single-dose formulations that are free of thimerosal as a preservative.
- For more product information and guidance, visit Seqirus' Flu360 website.
By purchasing with CNECT through McKesson distribution or direct from Moderna, you save 24-25% off standard GPO pricing.
Important Details
- Available to purchase through McKesson distribution and direct from Moderna.
- Pricing is net member pricing and no additional distributor markup should be applied.
- The U.S. government does not apply federal excise tax to COVID-19 vaccines
-
Moderna has provided the updated coding and packing information for its 2025-2026 COVID-19 vaccine portfolio.
- Get to know SPIKEVAX, the first and only FDA-approved COVID-19 vaccine for high-risk individuals as young as 6 months of age.
- Learn more about mNEXSPIKE®, an enhanced COVID-19 vaccine for patients at risk.
- Read guidance on individuals who should receive COVID-19 vaccination.
With RSV vaccines not eligible for Medicare reimbursement, our agreement with Moderna helps minimize your costs as you protect your aging population. With CNECT, you can access discounted pricing by purchasing direct from Moderna or through McKesson distribution.
Important Details
- Indication for RSV vaccines is for patients 60+ years old and high-risk patients 18–59 years old.
- Read about the latest indication update for mRESVIA®.
- Moderna's RSV vaccines are the only pre-filled syringe options on the market.
- Pricing is 22% lower than 2024-2025 pricing.
- Available to purchase through McKesson distribution and direct from Moderna.
- Pricing is member net pricing and no additional distributor markup should be applied.
- Review full mRESVIA® product and reimbursement information.
- RSV products may be returned based on the Moderna Returned Goods Policy and Procedures.